- Industry Insider: Personalized medicine studied (The Star-Ledger)
There's a big difference between promise and practicality. Medco Health Solutions is partnering with federal drug regulators to move beyond the potential of personalized medicine and determine how it can be used by doctors to provide patients with the most effective prescription drugs.
- Santarus to Present at Two September Investment Conferences (Business Wire via Yahoo! Finance)
SAN DIEGO----Santarus, Inc. , a specialty pharmaceutical company, today announced that Gerald T. Proehl, president and chief executive officer, will make presentations at the following investment community conferences during the month of September: Thomas Weisel Partners Healthcare Conference 2008 being held at the Four Seasons Hotel in Boston on Wednesday, September 3, 2008 at 3:15 p.m.
- Court says Astra's Prilosec patent infringed (Reuters via Yahoo! Singapore News)
(Adds details)
- (AFX UK Focus) 2008-08-20 17:50 UPDATE 1-Court says Astra's Prilosec patent infringed (Interactive Investor)
WASHINGTON, Aug 20 (Reuters) - A U.S. appeals court upheld an infringement finding against generic drug makers Apotex and Impax on Wednesday in a case brought by AstraZeneca to defend the patents for its popular heartburn drug Prilosec.
- Santarus to Present at Two September Investment Conferences (Centre Daily Times)
Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that Gerald T. Proehl, president and chief executive officer, will make presentations at the following investment community conferences during the month of September:
- New product revenue helps Perrigo to record quarter (Globes Online)
Sales of its consumer, pharmaceutical, and diagnostic products in Israel rose 24% to $48.8 million.
- Perrigo net surges in fiscal fourth quarter (Haaretz Daily)
Generic drugmaker Perrigo Co. posted a 46% rise in quarterly profit, helped by strong sales in its consumer healthcare segment, and set a fiscal 2009 earnings view that would meet or beat expectations.